Clinical Trials List
2026-03-01 - 2030-10-09
Phase III
Not yet recruiting9
ICD-10I10
Essential (primary) hypertension
ICD-9401.0
Malignant essential hypertension
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林柏志 無
- 賀立婷 無
- MAO-HSIN LIN 無
- 黃慶昌 無
- 廖敏村 無
- 洪啟盛 無
- JEN-KUANG LEE 無
- Chih-Fan Yeh 無
- 陳俊凱 無
- HUNG-JU LIN 無
- CHO-KAI WU 無
- 蔡承烜 無
- YEN-HUNG LIN 無
- Tzung-Dau Wang 無
- 陳盈憲 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
150 participants
-
Global
11000 participants
